Prof. Dr. ZAFER AKÇALI

Tıbbi Onkoloji Bilim Dalı



Tel : 0312 2466666 -
E-Posta : zakcali[at]baskent.edu.tr
  • Tıpta Yandal Uzmanlığı (2000), Gazi Üniversitesi, Tibbi Onkoloji (İç Hastaliklari)
  • Tıpta Uzmanlık (1997), Gazi Üniversitesi, İç Hastaliklari
  • Tıp Doktoru (1991), Hacettepe Üniversitesi, Tip

Çalışma Alanları


  • İÇ HASTALIKLARI

  • TIBBİ ONKOLOJİ (İÇ HASTALIKLARI)

Makaleler


  • Oğuz A, Keskin GS, Çolak D, Altundağ Ö, Akçalı Z. ;Treatment of Lymph Node-Negative, Early-Stage HER2-Positive Breast Cancer. J Clin Oncol, 2016; 34(6):639-640. ( SSCI : Social Sciences Citation Index )

  • Namal E, Ercetin C, Tokocin M, Akcali Z, Yigitbas H, Yavuz E, Celebi F, Totoz T, Pamukcu O, Saglam E. ;Survival effect of supportive care services for Turkish patients with metastatic gastric cancer. Asian Pacific Journal of Cancer Prevention, 2015; 16(3):1213-1217. ( SCI-Exp : Science Citation Index-Expanded (SCI dahil) )

  • Aydin K, Okutur S, Bozkurt M, Turkmen I, Namal E, Pilanci K, Ozturk A, Akcali Z, Dogusoy G, Demir O. ;Effect of epidermal growth factor receptor status on the outcomes of patients with metastatic gastric cancer: A pilot study.. ONCOLOGY LETTERS, 2014; 7(1):255-259. ( SCI-Exp : Science Citation Index-Expanded (SCI dahil) )

  • Yıldırım Y, Akçalı Z, Özyılkan Ö. ;Signet-ring cell carcinoma of the colon with leptomeningeal involvement. JOURNAL OF CLINICAL NEUROSCIENCE, 2010; 17(8):1051-1053. ( SCI-Exp : Science Citation Index-Expanded (SCI dahil) )

  • Calikusu Z, Yildirim Y, Akcali Z, Sakalli H, Bal N, Ozyilkan O. ;Prognostic Significance of the C-erbB-2 Expression in Turkish Non-Small Cell Lung Cancer Patients. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009; 10(3):479-482. ( SCI-Exp : Science Citation Index-Expanded (SCI dahil) )

  • Calikusu Z, Yesim Y, Zafer A, Hakan S, Nebil B, Ilker U, Ilker O. ;The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009; 28(97):1-6. ( SCI-Exp : Science Citation Index-Expanded (SCI dahil) )

  • Yıldırım Y, Özyılkan Ö, Bilezikçi B, Akçalı Z, Haberal M. ;Lack of Influence of Cyclooxygenese-2 Expression in Hepatocellular Carcinomas on Patient Survivalgiogenesis in breast carcinoma with adjuvant chemotherapy. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2008; 9(2):295-298. ( SCI-Exp : Science Citation Index-Expanded (SCI dahil) )

  • Yıldırım Y, Özyılkan Ö, Akçalı Z, Baştürk N. ;Drug interaction between capecitabine and warfarin: a case report and review of the literature. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2006; 44(2):80-82. ( SCI-Exp : Science Citation Index-Expanded (SCI dahil) )

  • Yamaç D, Çelenkoğlu G, Coşkun U, Akyürek N, Akçalı Z, Dursun A, Köybaşıoğlu F. ;Prognostic importance of COX-2 expression in patients with colorectal cancer. PATHOLOGY RESEARCH AND PRACTICE, 2005; 201(7):497-502. ( SCI-Exp : Science Citation Index-Expanded (SCI dahil) )

  • Ozdemir BH, Akcali Z, Haberal M. ;Hypercholesterolemia impairs angiogenesis in patients with breast carcinoma and, therefore, lowers the risk of metastases. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004; 122(5):696-703. ( SCI-Exp : Science Citation Index-Expanded (SCI dahil) )

  • Uner A, Akcali Z, Unsal DK. ;Serum levels of soluble E-selectin in colorectal cancer. NEOPLASMA, 2004; 51(4):269-274. ( SCI-Exp : Science Citation Index-Expanded (SCI dahil) )

  • Köseoğlu H, Yücel E, Işıklar İ, Türker İ, Akçalı Z, Haberal M. ;Joint pain and arthritis in renal transplant recipients and correlation with cyclosporine therapy. RHEUMATOLOGY INTERNATIONAL, 2003; 23(4):159-162. ( SCI-Exp : Science Citation Index-Expanded (SCI dahil) )

  • Gunel N, Akcali Z, Coskun U, Akyol, G, Yamac, D, Yenidunya, S. ;Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy. PATHOLOGY RESEARCH AND PRACTICE, 2002; 198(1):7-12. ( SCI-Exp : Science Citation Index-Expanded (SCI dahil) )

Bildiriler


  • Akçalı Z. ;Kolon Kanserli Olgu SUnumu. 1. Türkiye - Azerbaycan Onkoloji Günleri: Azerbeycan - Bakü; 10/09/2015 - 13/09/2015

  • Akçalı Z. ;Kullanım sıklığı artmakta olan yeni kemoterapiler ve kemoterapi kombinasyonları (FOLFIRINOX, Gemsitabin-Nab Paklitaksel, İksabepilon-Kapesitabin, Eribulin, Kabazitaksel). 21. Ulusal Kanser Kongresi: Antalya; 22/04/2015 - 26/04/2015

  • Akçalı Z. ;Medikal Onkolog Gözü İle Prostat Kanseri. Ufuk TIP İç Hastalıkları Günü: Ufuk Üniversitesi, Ankara; 05/12/2014